Please use this identifier to cite or link to this item:
|Title:||Expression and localization of homeodomain proteins DLX4/HB9 in normal and malignant human breast tissues|
|Citation:||Anticancer Research: international journal of cancer research and treatment, 2003; 23(2B):1479-1488|
|Publisher:||Int Inst Anticancer Research|
|Neufing, PJ; Kalionis, B; Horsfall, DJ; Ricciardelli, C; Stahl, J; Vivekanandan, S; Raymond, W; Tilley, WD|
|Abstract:||Background: Alterations in the control of gene expression is a key event in neoplastic transformation. Investigating the expression of transcription factors such as homeodomain proteins may therefore allow better characterization of molecular mechanisms underlying the transformation process. Materials and Methods: Expression of homeodomain proteins DLX4 and HB9 was detected by RT-PCR and immunohistochemically in 24 breast tumors and their corresponding non-malignant tissue. Results: Although the percentage of nuclei expressing both DLX4 (p=0.001) and HB9 (p=0.0001) is increased in breast carcinoma, their intensity of nuclear staining is decreased compared to non-malignant nuclei. Furthermore HB9 nuclear immunoreactivity decreased progressively with increasing tumor grade (p=0.001). Conclusion: These data suggest that the reduction in malignant nuclear DLX4 immunoreactivity is an earlier event in breast carcinogenesis than the progressive loss of HB9 expression observed with increasing tumor grade. With further study and in conjunction with standard criterion of pathology, these findings may help to predict the malignant behaviour of some breast cancers.|
|Description:||© 2003 International Institute of Anticancer Research|
|Appears in Collections:||Aurora harvest|
Obstetrics and Gynaecology publications
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.